Table 1.
Clinical features, age of onset, lifetime prevalence and pharmacological management of major mental disorders
Disorder | Core features | Associated features | Typical age of onset (years) | Lifetime prevalence (%) | Pharmacological management |
---|---|---|---|---|---|
ADHD |
InattentionHyperactivityImpulsivity |
Cognitive impairment |
7 to 12 |
5 [5] |
Psychostimulants (for example, methylphenidate) |
ASD |
Deficits in social communication and social interaction Restricted and repetitive behaviors |
Cognitive impairment Hallucinations Delusions |
<3 |
1 to 2 [6-8] |
No recommended drug treatment Medication used to treat comorbidities if present |
Schizophrenia |
Hallucinations Delusions Disorganized speech or behavior Apathy Lack of emotional reactivity |
Cognitive impairment Discrete episodes of elevated, irritable or agitated mood Episodes of low mood |
16 to 30 |
0.7 [9] |
Antipsychotics (for example, risperidone) |
Bipolar disorder |
Discrete episodes of elevated, irritable or agitated mood |
Episodes of low mood Hallucinations Delusions |
18 to 40 |
1 [10] |
Mood stabilizers (for example, lithium)Antipsychotics (for example, olanzapine) |
Major depressive disorder | Low mood Loss of interest or pleasure Lack of energy | Psychosis | 20 to 45 | 12.5 [10] | Antidepressants (for example, citalopram) |
ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder.